Literature DB >> 20530443

Transient increase in serum thymidine kinase 1 within one week after surgery of patients with carcinoma.

Zhishan Li1, Yinghong Wang, Jie Ma, Jie He, Ji Zhou, Ellen He, Sven Skog.   

Abstract

AIM: To investigate transient increases of thymidine kinase 1 in serum (STK1) after surgery of patients with carcinoma. PATIENTS AND METHODS: STK1 was determined before and within one week after surgery of carcinoma patients (non-small cell lung (NSCLC), n=25, oesophagueal, n=12, cardial, n=4,) by a chemiluminescent dot blot assay using anti-TK1 IgY antibody.
RESULTS: The mean age of the patients with high STK1 values after surgery was 63.2+/-8.7 years, while that for patients with stable/low STK1 values was 54.8+/-11.8 years; this was significantly different at P<0.05. Sixty-one percent of the patients with high STK1 values after surgery exhibited declining red blood cell (35%) or increasing white blood cell/neutrophil cell (29%) counts. The high STK1 values after surgery correlated with a prolonged operation execution time in anaemic patients (3.43+/-0.90 h), as compared non-anaemic patients (2.72+/-0.79 h). The high STK1 values also correlated with extensive surgery programs (oseophageal/ cardial carcinoma, 3.31+/-0.70 h, versus NSCLC, 2.44+/-0.63 h).
CONCLUSION: The transiently elevated STK1 values post-operation might be due to surgery-induced complications, such as anaemia and infection/inflammation, but also to operation execution times and age of patients. We suggest that STK1 should not be used within one week post-operation, but before surgery and after one month to avoid non-tumor-related increases in STK1, and thus misleading results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530443

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Serum thymidine kinase 1 activity in solid tumor (breast and colorectal cancer) patients treated with adjuvant chemotherapy.

Authors:  M Bolayirli; C Papila; G G Korkmaz; B Papila; F Aydoğan; A Karataş; H Uzun
Journal:  J Clin Lab Anal       Date:  2013-05       Impact factor: 2.352

2.  Thymidine kinase 1 as a diagnostic tumor marker is of moderate value in cancer patients: A meta-analysis.

Authors:  Yanqun Xiang; Hua Zeng; Xiang Liu; Hui Zhou; Ling Luo; Chaohui Duan; Xiaohong Luo; Haiyan Yan
Journal:  Biomed Rep       Date:  2013-05-28

3.  Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy.

Authors:  Colleen M O'Connor; Sabina Sheppard; Cassie A Hartline; Helen Huls; Mark Johnson; Shana L Palla; Sourindra Maiti; Wencai Ma; R Eric Davis; Suzanne Craig; Dean A Lee; Richard Champlin; Heather Wilson; Laurence J N Cooper
Journal:  Sci Rep       Date:  2012-02-13       Impact factor: 4.379

4.  RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma.

Authors:  Xing Gu; Bin Li; Mingming Jiang; Meng Fang; Jun Ji; Aihua Wang; Mengmeng Wang; Xiaoqing Jiang; Chunfang Gao
Journal:  Oncotarget       Date:  2015-08-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.